Evidence map›Paper›PMID 31355219›Full record

ArticleAnnals of translational medicine2019

In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States.

Rupak Desai, Upenkumar Patel, Hemant Goyal, Afrina Hossain Rimu, Dipen Zalavadia, Pardeep Bansal, Nihar Shah

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Rupak DesaiResearch Fellow, Atlanta VA Medical Center, Decatur, GA, USA.
Upenkumar PatelDepartment of Internal Medicine, Nassau University Medical Center, East Meadow, NY, USA.
Hemant GoyalDepartment of Internal Medicine, Mercer University School of Medicine, Macon, GA, USA.
Afrina Hossain RimuDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Dipen ZalavadiaDepartment of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, PA, USA.
Pardeep BansalDivision of Gastroenterology, The Wright Center for Graduate Medical Education, Scranton, PA, USA.
Nihar ShahGastro Florida, St. Petersburg, FL, USA.
The Wright Center for Graduate Medical Education · USAtlanta VA Medical Center · USMease Countryside Hospital · USMercer University · USNassau University Medical Center · USTexas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiterature suggests the role of cannabis (marijuana) as an anti-inflammatory agent. However, the impact of recreational marijuana usage on in-hospital outcomes of inflammatory bowel disease (IBD) remains indistinct. We assessed the outcomes of Crohn's disease (CD) as well as ulcerative colitis (UC) with

methodsThe Nationwide Inpatient Sample datasets (2010-2014) were queried to identify adults with CD and UC hospitalizations with cannabis use and linked complications using ICD-9 CM codes. Categorical and continuous variables were compared between propensity-matched cohorts using Chi-square and Student's

resultsPropensity-matched cohorts included 6,002 CD (2,999 cannabis users & 3,003 non-users) and 1,481 UC (742 cannabis users & 739 non-users) hospitalizations. In CD patients, prevalence of colorectal cancer (0.3%

conclusionsWe found a lower frequency of colorectal cancer, parenteral nutrition, anemia but a higher occurrences of active fistulizing disease or intraabdominal abscess formation, lower GI hemorrhage and hypovolemia in the CD cohort with cannabis usage. In patients with UC, frequency of complications could not be compared between the two cohorts, except a higher frequency of fluid and electrolyte disorders and hypovolemia, and a lower frequency of postoperative infections with cannabis use. A shorter LOS and lesser hospital charges were observed in both groups with recreational marijuana usage.

Indexed as

CannabisCrohn’s disease (CD)inflammatory bowel disease (IBD)in-hospital and postoperative complicationsNational (Nationwide) Inpatient Sampleoutcomesrecreational marijuanaulcerative colitis (UC)

Identifiers

PMID31355219
PMCPMC6614328
OpenAlexW2946808311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.